Rare diseases
Investigational molecules
Locations
Study on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)
BelgiumStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
BelgiumStudy on the Safety and Effectiveness of GSK5733584 with Dostarlimab and Carboplatin for Patients with Advanced Gynecological Tumors
BelgiumA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
BelgiumA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
BelgiumAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
BelgiumPhase 2 Study Evaluating Safety and Efficacy of Belzutifan in Adults with Solid Tumors
BelgiumLong‑Term Safety and Efficacy Study of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy
BelgiumStudy of the safety and immune response of gskvx000000077430 drug combination versus standard influenza vaccine in adults 18‑64 years
BelgiumEfficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years
BelgiumPhase 3 Study of Oral Orforglipron vs Weekly Dulaglutide in Children and Adolescents (10‑<18 years) with Type 2 Diabetes
BelgiumPhase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
